Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Dalens L, Niogret J, Richard C, Chevrier S, Foucher P, Coudert B, Lagrange A, Favier L, Westeel V, Kim S, Adotevi O, Chapusot C, Martin L, Arnould L, Kaderbhai CG, Boidot R. Dalens L, et al. Among authors: adotevi o. Mol Cancer. 2023 Jul 29;22(1):120. doi: 10.1186/s12943-023-01829-4. Mol Cancer. 2023. PMID: 37516818 Free PMC article.
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
Seyed N, Taheri T, Vauchy C, Dosset M, Godet Y, Eslamifar A, Sharifi I, Adotevi O, Borg C, Rohrlich PS, Rafati S. Seyed N, et al. Among authors: adotevi o. PLoS One. 2014 Oct 13;9(10):e108848. doi: 10.1371/journal.pone.0108848. eCollection 2014. PLoS One. 2014. PMID: 25310094 Free PMC article.
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.
Poussard M, Philippe L, Fredon M, Bôle-Richard E, Biichle S, Renosi F, Perrin S, Kroemer M, Limat S, Bonnefoy F, Daguindau E, Deconinck E, Gruson B, Saas P, Adotévi O, Garnache-Ottou F, Angelot-Delettre F. Poussard M, et al. Among authors: adotevi o. EJHaem. 2020 Dec 13;2(1):125-130. doi: 10.1002/jha2.149. eCollection 2021 Feb. EJHaem. 2020. PMID: 35846081 Free PMC article.
[Phenotypic and functional analysis of T lymphocytes in cancer patients].
Badoual C, Vingert B, Agueznay N, Adotevi O, Haicheur N, Molina T, Bruneval P, Fridman WH, Tartour E. Badoual C, et al. Among authors: adotevi o. Ann Pathol. 2005 Jun;25(3):211-9. doi: 10.1016/s0242-6498(05)80112-9. Ann Pathol. 2005. PMID: 16230947 Review. French.
Immunogenic HLA-B7-restricted peptides of hTRT.
Cortez-Gonzalez X, Sidney J, Adotevi O, Sette A, Millard F, Lemonnier F, Langlade-Demoyen P, Zanetti M. Cortez-Gonzalez X, et al. Among authors: adotevi o. Int Immunol. 2006 Dec;18(12):1707-18. doi: 10.1093/intimm/dxl105. Epub 2006 Oct 31. Int Immunol. 2006. PMID: 17077179
Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells.
Rabu C, Rangan L, Florenceau L, Fortun A, Charpentier M, Dupré E, Paolini L, Beauvillain C, Dupel E, Latouche JB, Adotevi O, Labarrière N, Lang F. Rabu C, et al. Among authors: adotevi o. Oncoimmunology. 2019 Jan 17;8(4):e1560919. doi: 10.1080/2162402X.2018.1560919. eCollection 2019. Oncoimmunology. 2019. PMID: 30906653 Free PMC article.
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N, Bismuth E, Bosset S, Adotevi O, Warnier G, Lacabanne V, Regnault A, Desaymard C, Amigorena S, Ricciardi-Castagnoli P, Goud B, Fridman WH, Johannes L, Tartour E. Haicheur N, et al. Among authors: adotevi o. J Immunol. 2000 Sep 15;165(6):3301-8. doi: 10.4049/jimmunol.165.6.3301. J Immunol. 2000. PMID: 10975847
109 results